In Vitro Diagnostics Market Report 2024-2034

In Vitro Diagnostics Market Report 2024-2034

The In Vitro Diagnostics Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Technological Advancements Propelling Industry Growth

The surge in precision, portability, and affordability of diagnostic technologies is significantly driving growth in the market. The global adoption of innovative in-vitro diagnostic (IVD) tests is gaining momentum, fuelled by the introduction of advanced and highly accurate clinical laboratory tests. For instance, in June 2023, Japan’s Ministry of Health, Labour, and Welfare granted approval for Toray Industries, Inc.'s Toray APOA2-iTQ, a diagnostic tool for pancreatic cancer. Likewise, in March 2023, the U.S. FDA approved Abbott’s pioneering blood test for Traumatic Brain Injury (TBI). The successful approval and deployment of such cutting-edge IVD tests for critical health conditions are poised to unlock substantial commercial opportunities, positioning companies at the forefront of this evolving landscape. This trend underscores the importance of investing in research and development to remain competitive and responsive to emerging healthcare needs.

Segment Analysis

In 2024, the reagents segment is projected to hold over 50% of the market share, and is expected to maintain its dominance with the highest compound annual growth rate (CAGR) projected from 2024 to 2034. This growth trajectory is driven by extensive research and development initiatives undertaken by major industry players to innovate novel reagents and diagnostic kits. A noteworthy example is BD’s market authorization in February 2023 for the BD Onclarity HPV Assay, which is used in conjunction with the ThinPrep Pap Test in the United States. Such advancements underscore the increasing emphasis on research and development aimed at enhancing rapid cancer diagnostics and precision medicine solutions, allowing companies to capitalize on specialized and lucrative niches within the in-vitro diagnostics (IVD) sector.

Additionally, in March 2023, QIAGEN entered into a collaboration with Servier to develop a companion diagnostic test for TIBSOVO, designed for treating acute myeloid leukaemia. This partnership exemplifies the industry's heightened focus on precision medicine, which is driving demand for innovative reagents and consumables. As the field of precision medicine continues to evolve, the need for novel products is expected to grow, positioning the reagents segment as a critical catalyst for market expansion. Companies that invest in this area will be well-positioned to lead in the competitive landscape of IVD solutions.

What Questions Should You Ask before Buying a Market Research Report?

• How is the in vitro diagnostics market evolving?
• What is driving and restraining the in vitro diagnostics market?
• How will each in vitro diagnostics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
• How will the market shares for each in vitro diagnostics submarket develop from 2024 to 2034?
• What will be the main driver for the overall market from 2024 to 2034?
• Will leading in vitro diagnostics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
• Who are the leading players and what are their prospects over the forecast period?
• What are the in vitro diagnostics projects for these leading companies?
• How will the industry evolve during the period between 2024 and 2034? What are the implications of
  
  in vitro diagnostics projects taking place now and over the next 10 years?


• Is there a greater need for product commercialisation to further scale the in vitro diagnostics market?
• Where is the in vitro diagnostics market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the in vitro diagnostics market today, and over the next 10 years:

• Our 367-page report provides 134 tables and 185 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them ‚Äì NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2034 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter‚Äôs Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Product

• Instruments
• Reagents & Kits

Test

• Clinical Chemistry
• Immunoassay/Immunochemistry
• Molecular Diagnostics
• Hematology
• Urinalysis
• Others

Application

• Cardiology
• Diabetes
• Oncology
• Infectious Diseases
• Nephrology
• Autoimmune Diseases
• Drug Testing/Pharmacogenomics
• Others

End-users

• Academic & Research Institutes
• Diagnostic Laboratories
• Hospitals
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific

• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

MEA

• GCC
• South Africa
• Rest of MEA

The report also includes profiles for some of the leading companies in the In Vitro Diagnostics Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

• QIAGEN
• BD
• BioM√©rieux SA
• F. Hoffmann-La Roche, Ltd.
• Quidel
• Ortho Corporation
• Abbott
• Agilent Technologies, Inc.
• Thermofisher Scientific, Inc.
• Siemens Healthineers AG
• Bio-Rad Laboratories, Inc.
• Danaher
• Sysmex Corporation
• Charles River Laboratories
• Quest Diagnostics Incorporated
• Illumina, Inc.
• Hologic
• Revvity
• Exact Sciences

Overall world revenue for In Vitro Diagnostics Market, 2024 to 2034 in terms of value the market will surpass US$100 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the In Vitro Diagnostics Market, 2024 to 2034 report help you?

In summary, our 360+ page report provides you with the following knowledge:

• Revenue forecasts to 2034 for In Vitro Diagnostics Market 2024 to 2034, with forecasts for Product, Test, Application, and End-users, each forecast at a global and regional level ‚Äì discover the industry‚Äôs prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2034 for five regional and 20 key national markets ‚Äì See forecasts for the In Vitro Diagnostics Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market ‚Äì including company profiles for 19 of the major companies involved in the In Vitro Diagnostics Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the In Vitro Diagnostics Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.